Known and novel fusion detection and research via amplicon-based target enrichment for Next Generation Sequencing (NGS) on Illumina sequencing platforms

OmniFusion™ RNA Lung Cancer Panel uses single primer amplification method to enables detection more than 530 known and unknown fusions associated with non-small cell lung cancer.
Fusion genes include 11 cancer driver genes ( ALK, CIT, MBIP, MET, NRG1, NTRK1, NTRK3, PDGFRA, RET, ROS1, TACC3). OmniFusion workflow allows detection of novel fusion partners and and splicing variants.
Compared to other methods such as qPCR, FISH, or Sanger sequencing, Paragon Genomics targeted fusion sequencing method allows robust multiplexed detection of variants using minimum sample input and a simple workflow.

OmniFusion RNA Lung Cancer Panel